
Sun Pharma added to Citi’s pan-Asia focus list with 35% upside
Brokerage firm Citi expects Sun Pharma’s innovation revenues to climb to $3.2 billion by FY30, up from $1.2 billion in FY25.

Brokerage firm Citi expects Sun Pharma’s innovation revenues to climb to $3.2 billion by FY30, up from $1.2 billion in FY25.

A day prior, sources had told CNBC-TV18 that Jusmiral Holdings was to sell up to 5.1% of its stake in Cohance Lifesciences Ltd. via block…

Hindalco said production at its Novelis Plant in Oswego, New York plant has been halted at the moment as it investigates the cause of the…

With this fund infusion, the promoter stake in Poonawalla Fincorp goes up from 62.43% to 63.97%. Poonawalla Fincorp’s Book Value Per Share (BVPS) also goes…

32 analysts have coverage on Avenue Supermarts, the Radhakishan Damani-promoted company, of which 11 have a “buy” rating, 10 have a “hold”, and another 11…

iValue Infosolutions is a value-added distributor and solutions aggregator in the enterprise technology space. The company bridges global Original Equipment Manufacturers (OEMs) with Indian enterprises…

Brent traded around $68 a barrel, after losing 0.8% on Wednesday, while West Texas Intermediate was near $64.

Mumbai-based stock broker Anand Rathi is set to launch its IPO for subscription next week on September 23. The issue will close on September 25,…

Sensex Today | Stock Market LIVE Updates: Nifty crossed an important level of 25,300 in the previous session and has now set its sights on…

Brokerage firm Motilal Oswal said that while depositories operate in a duopoly market and NSDL enjoys superior pricing power, the stock appears fairly valued with…